CVS CVS Health Corp

  1. Stocks
  2. Healthcare
  3. NYSE: CVS

Price (delayed)

$84.605

Market cap

$108.21B

P/E Ratio

22.03

Dividend/share

$2.66

EPS

$3.84

Enterprise value

$173.18B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 40

CVS Caremark Corporation (CVS Caremark), together with its subsidiaries, is a pharmacy health care provider in the United States. CVS Caremark provides pharmacy services through its pharmacy benefit management (PBM), ...

Highlights
CVS's price to earnings (P/E) is 71% lower than its last 4 quarters average of 75.8 and 25% lower than its 5-year quarterly average of 29.7
The net income has surged by 67% since the previous quarter and by 8% year-on-year
Sector: Healthcare
Industry: Healthcare Plans
Website: http://www.cvshealth.com
Peers: PETS WMT

Key stats

What are the main financial stats of CVS

CVS stock price

How has the CVS Health stock price performed over time
Intraday
-1.46%
1 week
-6.28%
1 month
-10.1%
1 year
10.77%
YTD
6.61%
QTD
-18.22%

Financial performance

How have CVS Health's revenue and profit performed over time
Revenue
$415.09B
Gross profit
$58.75B
Operating income
$8.29B
Net income
$4.89B
Gross margin
14.2%
Net margin
1.2%
The net margin has soared by 71% from the previous quarter
The net income has surged by 67% since the previous quarter and by 8% year-on-year
The operating income is up by 39% since the previous quarter but it has declined by 7% year-on-year
The company's operating margin rose by 33% QoQ but it fell by 13% YoY

Price vs fundamentals

How does CVS's price correlate with its fundamentals

Growth

What is CVS Health's growth rate over time

Valuation

What is CVS Health stock price valuation
CVS P/E details
P/E
22.03
P/B
1.35
P/S
0.26
EV/EBIT
19.47
EV/EBITDA
26.36
EV/Sales
0.42
CVS's price to earnings (P/E) is 71% lower than its last 4 quarters average of 75.8 and 25% lower than its 5-year quarterly average of 29.7
CVS Health's EPS has surged by 66% QoQ and by 7% YoY
CVS's equity is up by 3% YoY and by 2.9% QoQ
CVS's price to book (P/B) is 2.1% less than its 5-year quarterly average of 1.4 and 2.1% less than its last 4 quarters average of 1.4
The stock's price to sales (P/S) is 13% less than its 5-year quarterly average of 0.3 and 13% less than its last 4 quarters average of 0.3
The revenue has grown by 7% YoY

Efficiency

How efficient is CVS Health business performance
The return on assets has surged by 73% since the previous quarter and by 6% year-on-year
CVS's ROE has soared by 64% QoQ and by 8% YoY
CVS Health's return on invested capital has increased by 33% QoQ but it has decreased by 9% YoY
CVS Health's return on sales has increased by 31% QoQ but it has decreased by 16% YoY

Dividends

What is CVS's dividend history
Dividend details
DPS
$2.66
Dividend yield
3.14%
Payout ratio
69.3%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did CVS Health financials performed over time
CVS Health's total assets is 46% more than its total liabilities
The current ratio has grown by 9% year-on-year
CVS's quick ratio is up by 7% YoY
The debt is 4.3% less than the equity
CVS Health's debt to equity has decreased by 10% YoY and by 5% QoQ
The debt has contracted by 8% YoY and by 2.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.